Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Hepatic stellate cells (HSCs) are the key drivers of fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD), the fastest growing cause of hepatocellular carcinoma worldwide. HSCs are heterogenous, and a senescent subset of HSCs is implicated in hepatic fibrosis and HCC. Administration of anti-uPAR (urokinase-type plasminogen activator receptor) CAR T cells depletes senescent HSCs and attenuates fibrosis in murine liver injury models, including MASLD. However, the comprehensive features of senescent HSCs in MASLD, as well as their cellular ontogeny have not been characterized. Aims and Methods: Our aims were to comprehensively characterize and define the origin of senescent HSCs in human and murine MASLD by integrating senescence-associated beta galactosidase activity with immunostaining, flow cytometry and single nuclear RNA-sequencing (snRNAseq). We integrated the immunohistochemical profile with a senescence score applied to snRNAseq data to characterize senescent HSCs, and mapped the evolution of uPAR expression in MASLD. Results: Using pseudotime trajectory analysis, we establish that senescent HSCs arise from activated HSCs. While uPAR is expressed in MASLD, the magnitude and cell-specificity of its expression evolve with disease stage, such that in early disease, uPAR is more specific to activated and senescent HSCs, and in late disease, uPAR is also expressed by myeloid-lineage cells including Trem2+ macrophages and myeloid-derived suppressor cells. Furthermore, we identify novel surface proteins expressed on senescent HSCs in human and murine MASLD that could be exploited as therapeutic targets. Conclusions: These data define features of HSC senescence in human and murine MASLD, establishing an important blueprint to target these cells as part of future antifibrotic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citationGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
Research works printed but not linked: 28
- Higashi, 2017, Hepatic stellate cells as key target in liver fibrosis, Adv Drug Deliv Rev, 121, 27, 10.1016/j.addr.2017.05.007 · DOI · Paper page
- Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38 · DOI · Paper page
- Cogliati, 2023, Friend or foe? The elusive role of hepatic stellate cells in liver cancer, Nat Rev Gastroenterol Hepatol, 10.1038/s41575-023-00821-z · DOI · Paper page
- Pluquet, 2021, Cellular senescence and tumor promotion: role of the unfolded protein response, Adv Cancer Res, 150, 285, 10.1016/bs.acr.2021.01.001 · DOI
- Wagner, 2015, Overexpression of the novel senescence marker beta-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence, PLoS One, 10, 10.1371/journal.pone.0124366 · DOI · Paper page
- Li, 2020, FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome, Nat Cel Biol, 22, 728, 10.1038/s41556-020-0511-2 · DOI · Paper page
- Miyazoe, 2020, Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells, Biomed Rep, 12, 163
- Raza, 2021, Current treatment paradigms and emerging therapies for NAFLD/NASH, Front Biosci (Landmark Ed), 26, 206, 10.2741/4892 · DOI · Paper page
- Hallsworth, 2019, Lifestyle modification in NAFLD/NASH: facts and figures, JHEP Rep, 1, 468, 10.1016/j.jhepr.2019.10.008 · DOI · Paper page
- Oseini, 2017, Therapies in non-alcoholic steatohepatitis (NASH), Liver Int, 37, 97, 10.1111/liv.13302 · DOI · Paper page
- Itahana, 2007, Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay, Methods Mol Biol, 371, 21, 10.1007/978-1-59745-361-5_3 · DOI · Paper page
- Kostallari, 2022, Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis, Am J Physiol Gastrointest Liver Physiol, 322, G234, 10.1152/ajpgi.00254.2021 · DOI · Paper page
- Regulski, 2017, Cellular senescence: what, why, and how, Wounds, 29, 168
- Thomas, 2003, PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification, Nucleic Acids Res, 31, 334, 10.1093/nar/gkg115 · DOI · Paper page
- Bolte, 2006, A guided tour into subcellular colocalization analysis in light microscopy, J Microsc, 224, 213, 10.1111/j.1365-2818.2006.01706.x · DOI · Paper page
- Jin, 2017, Hepatic stellate cell interferes with NK cell regulation of fibrogenesis via curcumin induced senescence of hepatic stellate cell, Cell Signal, 33, 79, 10.1016/j.cellsig.2017.02.006 · DOI
- Yang, 2021, Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice, Hepatology, 74, 2774, 10.1002/hep.31987 · DOI · Paper page
- Zhang, 2021, Heterogeneity of hepatic stellate cells in fibrogenesis of the liver: insights from single-cell transcriptomic analysis in liver injury, Cells, 10, 10.3390/cells10082129 · DOI
- Zisser, 2021, Hepatic stellate cell activation and inactivation in NASH-fibrosis-roles as putative treatment targets?, Biomedicines, 9, 10.3390/biomedicines9040365 · DOI · Paper page
- Su, 2021, Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver, iScience, 24, 10.1016/j.isci.2021.103233 · DOI · Paper page
- Zhu, 2023, CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor, Cell Discov, 9, 25, 10.1038/s41421-023-00529-z · DOI · Paper page
- Xi, 2021, Protocol for executing and benchmarking eight computational doublet-detection methods in single-cell RNA sequencing data analysis, STAR Protoc, 2
- Dal-Secco, 2015, A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury, J Exp Med, 212, 447, 10.1084/jem.20141539 · DOI · Paper page
- Choe, 2021, SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma, Sci Transl Med, 13, 10.1126/scitranslmed.abe7378 · DOI · Paper page
- Tousley, 2023, Co-opting signalling molecules enables logic-gated control of CAR T cells, Nature, 615, 507, 10.1038/s41586-023-05778-2 · DOI · Paper page
- Haque, 2019, CD206(+) tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production, Sci Rep, 9, 10.1038/s41598-019-51149-1 · DOI
- Guo, 2017, M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma, Oncotarget, 8, 44465, 10.18632/oncotarget.17973 · DOI · Paper page
- Bruna, 2021, Pro-tumorigenic macrophage infiltration in oral squamous cell carcinoma and possible macrophage-aimed therapeutic interventions, Front Oncol, 11, 10.3389/fonc.2021.675664 · DOI
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02095-6 · Cited by 317
Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Han, Y., Zhang, X., Franco, A. C., Kim, S. Y., Wyles, S. P., Prakash, Y. S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00601-2 · Cited by 45
Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
Lu, H., Huang, J., Wang, Y.-C., Casals, E., Casals, G., & Zeng, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103933 · Cited by 19
“Similarly, senescence-associated macrophages (SAMs), identified by CD36 and p16INK4a, contribute to ECM remodelling by producing MMP-12, despite their role in clearing senescent HSCs [90,91].”
Yashaswini, C. N., Cogliati, B., Qin, T., To, T., Williamson, T., Papp, T. E., Li, K., Rasul, R., Chen, L., Lightstone, A., et al. (2025) · doi:10.1101/2025.02.25.640143 · Cited by 13
Self-citation
Metadata
- Authors
- Yashaswini, C. N., Qin, T., Bhattacharya, D., Amor, C., Lowe, S., Lujambio, A., Wang, S., & Friedman, S. L.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2024-08
- Volume
- 81
- Issue
- 2
- Pages
- 207-217
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4392930808
- Cited by
- 83
- References
- 31
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 355 d)
- Funders
- National Center for Advancing Translational Sciences
- National Institutes of Health (P30CA045508, S10OD026880, S10OD030463)
- Icahn School of Medicine at Mount Sinai (UL1TR004419)
- American Gastroenterological Association Research Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis. https://app.cochat.ai/papers/10.1016/j.jhep.2024.03.014
- The paper
- Yashaswini, C. N., Qin, T., Bhattacharya, D., Amor, C., Lowe, S., Lujambio, A., Wang, S., & Friedman, S. L. (2024). Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2024.03.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.